These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9159323)
1. Cyclosporine as cause of thrombotic microangiopathy after renal transplantation. Miller BW; Hmiel SP; Schnitzler MA; Brennan DC Am J Kidney Dis; 1997 May; 29(5):813-4. PubMed ID: 9159323 [No Abstract] [Full Text] [Related]
2. Causes of acute thrombotic microangiopathy in patients receiving kidney transplantation. Jumani A; Hala K; Tahir S; Al-Ghamdi G; Al-Flaiw A; Hejaili F; Qureshi J; Raza H; Ghalib M; Khader AA Exp Clin Transplant; 2004 Dec; 2(2):268-72. PubMed ID: 15859940 [TBL] [Abstract][Full Text] [Related]
4. Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation. Luciani J; Benalia H; Bitker MO; Mouquet C; Chartier-Kastler E; Ourhama S; Jacobs C; Chatelain C; Viars P Transplant Proc; 1993 Jun; 25(3):2302. PubMed ID: 8516907 [No Abstract] [Full Text] [Related]
5. Sever lower gastro-intestinal bleeding by CMV in a kidney transplant with low-dose immunosuppression. Ríos A; Ruiz J; Rodríguez JM; Parrilla P Nefrologia; 2016; 36(4):454-5. PubMed ID: 26873549 [No Abstract] [Full Text] [Related]
6. Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy. Kosch M; Könecke J; Hausberg M; Kisters K Clin Nephrol; 2001 Dec; 56(6):S35-6. PubMed ID: 11770811 [No Abstract] [Full Text] [Related]
7. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients. Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284 [No Abstract] [Full Text] [Related]
8. Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary? Smith SR; Butterly DW; Conlon PJ; Harland RC; Emovon OE Transplant Proc; 1998 Aug; 30(5):2097-9. PubMed ID: 9723404 [No Abstract] [Full Text] [Related]
9. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome. Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835 [TBL] [Abstract][Full Text] [Related]
10. Severe vital depression as the presenting feature of cyclosporin-A-associated thrombotic microangiopathy. van der Molen LR; van Son WJ; Tegzess AM; Stegeman CA Nephrol Dial Transplant; 1999 Apr; 14(4):998-1000. PubMed ID: 10328490 [No Abstract] [Full Text] [Related]